Expansion of a novel lead targeting M. tuberculosis DHFR as antitubercular agents
Kalicharan Sharma(Indo Soviet Friendship College of Pharmacy), Mymoona Akhter(Jamia Hamdard), Shakir Ali(Jamia Hamdard), M. S. Zaman(Jamia Hamdard), Omprakash Tanwar(Jamia Hamdard), Mohammad Mumtaz Alam(Jamia Hamdard), Dharmarajan Sriram(Birla Institute of Technology and Science, Pilani), Vagolu Siva Krishna(Birla Institute of Technology and Science, Pilani)
Cited by 21
Related Papers
Omicron SARS-CoV-2 variant: Unique features and their impact on pre-existing antibodies
|Journal of Autoimmunity|2021|234
Quinoline‐derivatives as privileged scaffolds for medicinal and pharmaceutical chemists: A comprehensive review
|Chemical Biology & Drug Design|2022|92
Ganoderic acid loaded nano-lipidic carriers improvise treatment of hepatocellular carcinoma
|Drug Delivery|2019|85
Deconvoluting the dual hypoglycemic effect of wedelolactone isolated from<i>Wedelia calendulacea</i>: investigation<i>via</i>experimental validation and molecular docking
|RSC Advances|2018|56
RETRACTED ARTICLE: Melastoma malabathricum Linn attenuates complete freund’s adjuvant-induced chronic inflammation in Wistar rats via inflammation response
|BMC Complementary Medicine and Therapies|2016|53